September 2021 – The Journal of Pharmacology & Experimental Therapeutics
A GluN2B-selective inhibitor of NMDA receptor function with enhanced potency at acidic pH and oral bioavailability for clinical use
March 2015 – Neuron
Context-Dependent GluN2B-Selective Inhibitors of NMDA Receptor Function Are Neuroprotective with Minimal Side Effects
February 2014 – Neurocritical Care
pH-Sensitive NMDA Inhibitors Improve Outcome in a Murine Model of SAH